No one has accused Anavex of similar research mainipulation as Cassava (SAVA)
Anavex’s trial data is on the up and up.
The sigma-1 receptor which is activated (agonized) by Anavex’s Blarcamesine and Anavex 3-71 have hundreds if not thousands of independent research regarding the MOA ( mechanism of action) of Blarcamesine and Anavex 3-71
Anavex Life Sciences has over 700 people currently taking Blarcamesine each and every day.